Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) reached a new 52-week high during trading on Monday . The company traded as high as $9.15 and last traded at $8.94, with a volume of 42392 shares traded. The stock had previously closed at $8.84.
Fresenius SE & Co. KGaA Trading Up 0.8 %
The company has a fifty day moving average price of $8.23 and a two-hundred day moving average price of $7.59. The firm has a market cap of $20.17 billion, a P/E ratio of 12.08 and a beta of 1.05.
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.22 earnings per share for the quarter. The company had revenue of $5.83 billion during the quarter. As a group, sell-side analysts expect that Fresenius SE & Co. KGaA will post 0.81 EPS for the current year.
Fresenius SE & Co. KGaA Company Profile
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Further Reading
- Five stocks we like better than Fresenius SE & Co. KGaA
- Conference Calls and Individual Investors
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- 3 Warren Buffett Stocks to Buy Now
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- Comparing and Trading High PE Ratio Stocks
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
